The levels of MICA, MICB and ULBP1-3 were assessed by flow cytometry. NK cell, NKG2D The treatment of glioblastoma remains a major challenge in the field of neuro-oncology. The current standard of care includes surgery treatment, radiotherapy, and alkylating chemotherapy. The median survival instances with this treatment are
Daily Archives: May 1, 2026
1 post